



Cite this article: Smits FM, Geuze E, Schutter
DJLG, van Honk J, Gladwin TE (2021). Effects
of tDCS during inhibitory control training on
performance and PTSD, aggression and
anxiety symptoms: a randomized-controlled
trial in a military sample. Psychological
Medicine 1–11. https://doi.org/10.1017/
S0033291721000817
Received: 25 August 2020
Revised: 19 January 2021
Accepted: 22 February 2021
Key words:
Aggression; anxiety; inferior frontal gyrus;





© The Author(s), 2021. Published by
Cambridge University Press. This is an Open
Access article, distributed under the terms of
the Creative Commons Attribution licence
(http://creativecommons.org/licenses/by/4.0),
which permits unrestricted re- use,
distribution and reproduction, provided the
original article is properly cited.
Effects of tDCS during inhibitory control
training on performance and PTSD, aggression
and anxiety symptoms: a randomized-
controlled trial in a military sample
Fenne M. Smits1,2 , Elbert Geuze1,2 , Dennis J. L. G. Schutter3 ,
Jack van Honk3,4,5 and Thomas E. Gladwin6,7
1Brain Research & Innovation Centre, Ministry of Defence, Utrecht, the Netherlands; 2Department of Psychiatry,
UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands; 3Experimental Psychology,
Helmholtz Institute, Utrecht University, Utrecht, the Netherlands; 4Department of Psychiatry and Mental Health,
University of Cape Town, Cape Town, South Africa; 5Institute of Infectious Disease and Molecular Medicine,
University of Cape Town, Cape Town, South Africa; 6Behavioural Science Institute, Radboud University Nijmegen,
Nijmegen, The Netherlands and 7Institute for Lifecourse Development, University of Greenwich, London, UK
Abstract
Background. Post-traumatic stress disorder (PTSD), anxiety, and impulsive aggression are
linked to transdiagnostic neurocognitive deficits. This includes impaired inhibitory control
over inappropriate responses. Prior studies showed that inhibitory control can be improved
by modulating the right inferior frontal gyrus (IFG) with transcranial direct current stimula-
tion (tDCS) in combination with inhibitory control training. However, its clinical potential
remains unclear. We therefore aimed to replicate a tDCS-enhanced inhibitory control training
in a clinical sample and test whether this reduces stress-related mental health symptoms.
Methods. In a preregistered double-blind randomized-controlled trial, 100 active-duty mili-
tary personnel and post-active veterans with PTSD, anxiety, or impulsive aggression symp-
toms underwent a 5-session intervention where a stop-signal response inhibition training
was combined with anodal tDCS over the right IFG for 20 min at 1.25 mA. Inhibitory control
was evaluated with the emotional go/no-go task and implicit association test. Stress-related
symptoms were assessed by self-report at baseline, post-intervention, and after 3-months
and 1-year follow-ups.
Results. Active relative to sham tDCS neither influenced performance during inhibitory con-
trol training nor on assessment tasks, and did also not significantly influence self-reported
symptoms of PTSD, anxiety, impulsive aggression, or depression at post-assessment or fol-
low-up.
Conclusions. Our results do not support the idea that anodal tDCS over the right IFG at 1.25
mA enhances response inhibition training in a clinical sample, or that this tDCS-training
combination can reduce stress-related symptoms. Applying different tDCS parameters or
combining tDCS with more challenging tasks might provide better conditions to modulate
cognitive functioning and stress-related symptoms.
Introduction
Post-traumatic stress disorder (PTSD) and anxiety are mental health disorders that are difficult
to treat, particularly among military patients (Spinhoven et al., 2016; Straud, Siev, Messer, &
Zalta, 2019). New treatment targets may be provided by finding ways to restore deficits in neu-
rocognitive processes. Across patients with PTSD, anxiety, and impulsive aggression, dysregu-
lated neurocognitive processes center around hyperresponsive limbic regions including the
amygdala and (dorsal) anterior cingulate cortex (ACC) (Craske et al., 2017; Davidson,
Putnam, & Larson, 2000; Hayes, Hayes, & Mikedis, 2012) and hyporesponsive regions in
the lateral and medial prefrontal cortex (PFC), accompanied by impairments in cognitive func-
tions like working memory, cognitive flexibility, and inhibitory control (Etkin, Gyurak, &
O’Hara, 2013).
Of these cognitive functions, inhibitory control particularly may play a vital role. Inhibitory
control comprises the ability to withhold automatic or context-inappropriate responses in
order to maintain goal-directed behavior. PTSD patients display impairments specifically on
inhibitory control tasks (DeGutis et al., 2015) and hypoactivation in the brain’s hub of inhibi-
tory control: the right inferior frontal gyrus (IFG) (Aron, Robbins, & Poldrack, 2014; Hayes
et al., 2012). It is proposed that failing inhibition of inappropriate stress responses, memories,
and motor reactions to fear-evoking stimuli contributes to symptoms of hyperarousal and
irritability, and in turn, avoidance of fear- or trauma-related triggers and defensive aggression
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(Aupperle, Melrose, Stein, & Paulus, 2012; van Rooij & Jovanovic,
2019). Moreover, impairments in the prefrontal inhibitory control
circuit may impede therapy response (Marwood, Wise, Perkins, &
Cleare, 2018). An appealing question is therefore whether the dys-
regulated inhibitory control circuit poses a potential therapeutic
target.
To restore dysregulated brain circuits, transcranial direct cur-
rent stimulation (tDCS) may play a role by promoting neural plas-
ticity (Yavari, Jamil, Mosayebi Samani, Vidor, & Nitsche, 2018).
While tDCS alone may not effectively modulate emotional dis-
tress (Smits, Schutter, van Honk, & Geuze, 2020), deficient cogni-
tive processes underlying stress-related disorders – such as
inhibitory control – could comprise convenient tDCS targets in
this context. For example, single-session tDCS over the right
IFG has shown to increase inhibitory control task performance
(Mayer et al., 2020; Schroeder, Schwippel, Wolz, & Svaldi,
2020). Inhibitory control can also be enhanced with other techni-
ques used to modulate right IFG functioning (e.g. transcranial
magnetic stimulation or neurofeedback by functional magnetic
resonance imaging) (Alegria et al., 2017; Zandbelt,
Bloemendaal, Hoogendam, Kahn, & Vink, 2013). Interestingly,
multiple-session tDCS combined with response inhibition train-
ing has demonstrated cumulative effects on inhibitory control
performance in healthy volunteers (Ditye, Jacobson, Walsh, &
Lavidor, 2012). Increasing evidence now suggests that combining
multiple tDCS sessions with cognitive training may produce
stronger, more consistent, and longer-lasting effects on and
beyond the trained function (Berryhill & Martin, 2018).
Combining multiple-session tDCS with inhibitory control train-
ing may thus provide opportunities to target impairments in
the prefrontal inhibitory control function. The next step in
exploring the potential of tDCS-enhanced inhibitory control
training in treating stress-related disorders is to replicate these
effects in a clinical sample and test whether this beneficially
affects clinically relevant outcomes.
In this randomized-controlled trial (RCT), we applied a 5-ses-
sion inhibitory control training with anodal tDCS over the right
IFG in military veterans and active-duty personnel with PTSD,
anxiety, or impulsive aggression. As a primary outcome, we tested
whether tDCS enhanced inhibitory control during training. As
secondary outcomes, we tested tDCS-related changes in inhibitory
control performance and stress-related symptoms over the inter-
vention period.
Methods
This double-blind RCT was preregistered at the Netherlands Trial
Register (www.trialregister.nl, ID: NL5709).
Participants
Military veterans and active-duty personnel of the Dutch Ministry
of Defence were recruited between May 2016 and October 2019
through advertisements in mental healthcare outpatient clinics.
The following inclusion criteria were applied: 18–60 years of
age, fulfilling diagnostic criteria and receiving treatment for
PTSD, an anxiety disorder or impulsive aggression problems.
Exclusion criteria: primary diagnosis for major depressive dis-
order (comorbid depression was not a reason for exclusion), sub-
stance addiction, severe neurological or psychotic disorder,
serious head trauma or surgery, large metal or ferromagnetic
parts in the head, implanted pacemaker or neurostimulator,
pregnancy, skin damage on the scalp, and neurostimulation in
the past month. Psychoactive medication use was assessed.
Patients were asked to keep stable doses during the tDCS inter-
vention, starting two weeks in advance. The a priori computed
sample size was 96 [48 per group; computed in G*Power 3.1
(Faul, Erdfelder, Lang, and Buchner, 2007) with α = 0.05, β =
90%, and Cohen’s f = 0.34 based on results from Ditye and cow-
orkers (Ditye et al., 2012) lowered by 10%]. The medical ethical
committee of the University Medical Center Utrecht approved
the study. All participants provided written informed consent.
The authors assert that all procedures contributing to this work
comply with the ethical standards of the relevant national and
institutional committees on human experimentation and with
the Helsinki Declaration of 1975, as revised in 2008.
Procedure and randomization
Figure 1b depicts the study procedure. First, a clinical diagnostic
interview was done, including the SCID-I for DSM-IV-R Axis-I
disorders (First, Spitzer, Gibbon, & Williams, 2002), DSM-5
intermittent explosive disorder criteria (Coccaro, 2012), and
M.I.N.I. ADHD criteria (Sheehan et al., 1998). Patients were
then allocated to active or sham tDCS (1:1) by the next available
stimulator-activating code from a randomized list (Matlab ‘rand’
function; 20 codes for active tDCS, 20 codes for sham), stratified
by eye movement desensitization and reprocessing (EMDR) ther-
apy v. cognitive behavioral therapy (CBT) to avoid confounding
with psychotherapy effects. Experimenters were blind for
code-to-condition correspondence, and, although not formally
tested, patients were not expected to know whether they received
sham or active tDCS (Ambrus et al., 2012). The interview and
tDCS sessions were carried out in test rooms at the University
Medical Center Utrecht. Pre- and post-assessments took place
online through a weblink.
tDCS
Participants received five tDCS sessions, with 1–5 days between
sessions depending on the participant’s availability. TDCS was
applied for 20 min over two 5 × 7 cm electrodes by a
neuroConn DC-stimulator Plus with settings based on Ditye’s
study (Ditye et al., 2012): 1.25 mA (fade-in: 8 s), anode on the
crossing point between 10-20 system EEG positions T4-Fz and
F8-Cz, cathode over the left orbital region (see Fig. 1b). Sham
tDCS was applied by a 16-s fade-in fade-out stimulation at the
start and end of the stimulation period, interleaved by occasional
15 ms pulses of 0.11 mA. The emotional state was assessed before
and after each session by the STAI-6 (Marteau & Bekker, 1992),
together with possible tDCS side effects scored from 1 (‘absent’)
to 4 (‘severe’) (Brunoni et al., 2011).
Inhibitory control training
TDCS was combined with a 30-min training on the stop-signal
task, see Fig. 1b (Logan, Cowan, & Davis, 1984). Participants
were instructed to quickly press the left or right arrow button
upon stimulus presentation (circle or square), but to withhold
their response when a stop-signal was heard: an auditory ‘beep’
(25% of trials, 0–400 ms stop-signal onset delay). To titrate suc-
cessful stop-signal response inhibition to ∼50%, stop-signal delays
increased or decreased with 50 ms after successful or unsuccessful
stopping, respectively. Six blocks of 100 trials were interleaved by
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1-min breaks. One extra block with 20 no-signal trials to prevent
response slowing was excluded from data analysis. The stop-signal
response time (SSRT), the time it takes to stop an already initiated
response which reflects inhibitory control, was computed by the
independent horse-race model (Logan et al., 1984) and consti-
tuted our primary outcome measure. Response speed (RT on
no-signal trials) was taken as a control measure.
Secondary outcome measures of inhibitory control
Prolonged effects of training combined with active v. sham tDCS
on inhibitory control were tested by comparing performance at
pre- v. post-assessment on the emotional go/no-go task and the
implicit association task (IAT).
The go/no-go task was used to measure the inhibition of pre-
potent responses driven by a high frequency of go-stimuli.
Participants were instructed to rapidly tap on the space bar
when a go-stimulus appeared (80% of trials), and to withhold
their response to a no-go-stimulus (20% of trials). On 50% of
all trials, ‘go’- and ‘no-go’-stimuli (‘[]’ and ‘][’) were superim-
posed on male face images with a neutral or angry expression
[Bochum Emotional Stimulus Set, BESST (Thoma, Soria Bauser,
and Suchan, 2013)], to assess threat-related distraction on inhib-
ition performance (Gladwin, Möbius, & Vink, 2019). Stimuli were
presented for 600 ms with a 250–350 ms inter-trial interval in 7
blocks of 40 trials. The median reaction time (RT) over go-trials
was used to assess effects on response speed, and accuracy repre-
sented the ability to correctly execute or inhibit responses. The
first (practice) block, the first four trials of each block, post-error
trials, sequences of ⩾ 5 consecutive no-response go-trials, and
trials with an RT<170 ms were excluded from analysis (on aver-
age, 18.5% of trials were excluded).
The IAT was used to measure inhibition of prepotent
responses driven by automatic associations. We used the standard
IAT with flower and insect names as target words and pleasant
and unpleasant words as attributes (Greenwald, McGhee, &
Schwartz, 1998). Participants were instructed to classify target
and attribute words as quickly as possible by pressing the ‘F’ or
‘J’ button. Each category contained 15 practice trials and 60 test
trials. Better inhibition of the automatic response attenuates the
increase in response latency and error rate on incongruent trials
(the IAT effect). The D600 IAT effect was computed by adding
600 ms to incorrect response RTs, and dividing the difference in
congruent v. incongruent trial RTs by the RT standard deviation.
In addition, a Quad model (Conrey, Sherman, Gawronski,
Hugenberg, & Groom, 2005) was estimated based on trial-level
classification errors using a multinomial tree processing model
in R (Singmann & Kellen, 2013), to quantify the ‘overcoming
bias’ (the likelihood that the automatic association is overcome),
representing the unique contribution of inhibitory control on
IAT performance.
At post-assessment, participants additionally performed a
dot-probe task. Unlike the inhibitory control tasks, this task
assesses attentional biases for threat. The main outcomes of this
task are described in the online Supplementary Materials.
Symptoms
Beside baseline symptom assessment by the diagnostic interview,
symptom levels were assessed at pre-, post-, and follow-up-
assessments by self-report scales including the PTSD Checklist
Fig. 1. (a) CONSORT study flow diagram. FU-3m = 3-months follow-up assessment. FU-1yr = 1-year follow-up assessment. (i) Reasons: delayed discovery of tDCS
safety contraindication (n = 1), time conflict with other treatment/work (n = 1). (ii) Reasons: panic symptoms at tDCS work-up session 1 (n = 1), time conflict
with other treatment (n = 1). (iii) Reasons: time conflict with other treatment/work (n = 2). (iv) Reasons: psychoactive drug changes during intervention (n = 1),
>5 days between tDCS sessions (n = 1), tDCS applied at <1.25 mA on request of participant (n = 1); (v) Reasons: inadequate performance of the stop-signal task
(n = 1); (b) Overview of study procedure.
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for DSM-5 (PCL-5) (Weathers et al., 2013), the trait version of the
positive and negative affect schedule (PANAS) (Watson, Clark, &
Tellegen, 1988), and the STAXI-2 (Spielberger, 1999). TDCS
effects on disorder-specific symptoms of PTSD, anxiety, and
impulsive aggression were tested only within subgroups
of participants who fulfilled the criteria for the corresponding
diagnosis. Depressive symptoms and general mental well-being
were assessed using the Beck Depression Inventory 2nd edition
(BDI-II) (Beck, Steer, & Brown, 1996) and the Outcome
Questionnaire 45 (OQ45) (Lambert, Finch, & Maruish, 2004).
At baseline, childhood trauma and impulsivity traits were assessed
by the Dutch version of the childhood trauma questionnaire short
form (CTQ-SF) (Bernstein et al., 2003) and Barrett’s Impulsivity
Scale (BIS-11) (Patton, Stanford, & Barratt, 1995).
Statistical analysis
Continuous outcomes were analyzed in mixed-design ANOVAs
in R (R Foundation for Statistical Computing, 2016) with the
‘rstatix’ package (Kassambara, 2020). Trial-level accuracy data
were, as recommended (Jaeger, 2008), analyzed in binary logistic
mixed-effects models with the ‘lme4’ package (Bates, Mächler,
Bolker, & Walker, 2015) with a random intercept for the partici-
pant, where p values were obtained in likelihood ratio tests of
the full model v. a model without the effect. Stimulation group
(active v. sham tDCS) was treated as between-subjects factor,
Time (tDCS sessions 1–5, or pre-assessment, post-assessment
and follow-ups) as within-subjects factor, and their interaction
would reflect whether the active tDCS intervention induced
different time effects than the sham intervention. Age and Use
of psychoactive medication (yes/no) were included as covariates.
Where the assumption of sphericity was violated, Greenhouse-
Geisser-corrected results are reported. Effects are reported as sig-
nificant at p < 0.05. Effect sizes are reported as generalized
eta-squared (η2G).
Additionally, to provide possibly useful information for neuro-
cognitive models about the relationship between inhibitory con-
trol and stress-related symptoms, we computed baseline
correlations between the inhibitory control tasks and symptom
scores at pre-assessment. Also, to explore if improved inhibitory
control could drive symptom relief, we tested in a regression
model if (i) SSRT improvement (ΔSSRT = SSRT session 5− SSRT
session 1) or (ii) the achieved SSRT level on session 5 predicted
reductions in PTSD, anxiety, or anger symptoms (Δsymptom
score = post-score− pre-score). Here, Stimulation group was
always entered as a first predictor to control for effects attributable
to tDCS.
Results
Figure 1a shows the study flow. As can be seen in Table 1, the
active tDCS and sham groups matched on most factors. Yet, des-
pite random group allocation, females and post-active veterans
were overrepresented in the active tDCS group, while patients
with an anxiety diagnosis were overrepresented in the sham
group. Because prefrontal tDCS outcomes may depend on gender
(Dedoncker, Brunoni, Baeken, & Vanderhasselt, 2016), we
repeated analyses without the female participants. This did not
significantly change results.
Safety
The intervention was well tolerated and no serious adverse events
were reported. The only tDCS-related side effects were mild itch-
ing and burning sensations on the scalp (mean severity
scores ± S.D. itching – active tDCS: 1.7 ± 0.7 v. sham: 1.4 ± 0.6;
burning – active tDCS: 1.6 ± 0.7 v. sham: 1.3 ± 0.6; p’s < 0.001),
and some tDCS participants noticed light skin redness that
was absent in the sham group (active tDCS: 1.1 ± 0.6 v. sham:
1.0 ± 0.1; p = 0.010). Emotional state fluctuations during tDCS
sessions were negligible and did not significantly differ between
stimulation groups (mean STAI-6 item absolute change score:
0.26 ± 0.48; effects of Stimulation group and Stimulation group ×
STAI-6 item on change scores: p’s > 0.18).
Primary outcome: inhibitory control training on the
stop-signal task
Three participants showed very slow response times on session
1, preventing reliable SSRT computations. As this comprised <5%
of the data, the a priori defined analyses were performed on the
remaining sample (46 tDCS and 47 sham) (Jakobsen, Gluud,
Wetterslev, & Winkel, 2017). A mean stop-signal response accuracy
of 51.5% ± 7% confirmed successful stop-signal delay titration.
The active v. sham tDCS groups did not significantly differ in
overall SSRT scores or in SSRT improvement over sessions, as
indicated by the non-significant effects of Stimulation group
and the Stimulation group × Time interaction (respectively: p =
0.239, η2G = 0.011; p = 0.582, η
2
G = 0.002). Only the main effect
of Time was significant ( p < 0.001, η2G = 0.019). SSRT changes
between sessions were tested with post-hoc Bonferroni-corrected
pairwise t tests; the SSRT significantly decreased from session 1
to session 2 and all following sessions, from session 2 to session
3 and all following sessions, and from session 3 to session 5
( p’s < 0.01), see Fig. 2. When Diagnosis was entered as an
additional between-subjects factor to explore possible differences
between patient subgroups, the tDCS related effects remained
non-significant (Stimulation group: p = 0.255, η2G = 0.011;
Stimulation group × Time: p = 0.905, η2G < 0.001; Stimulation group ×
Time ×Diagnosis: p = 0.201, η2G = 0.009). However, beside a main
effect of Time ( p < 0.001, η2G = 0.018), a significant Time ×
Diagnosis interaction appeared ( p = 0.005, η2G = 0.020). Based on vis-
ual inspection of the SSRTs per subgroup, the interaction seemed to
reflect a relatively strong SSRT decrease in the PTSD subgroup com-
pared to the anxiety and aggression subgroups (see online
Supplementary Fig. S2). Next, despite the underpowered 2 × 5
mixed design for the diagnosis subgroups, the subgroups were ana-
lyzed separately. The main effect of Time remained significant
among PTSD patients ( p = 0.014, η2G = 0.028), and was non-
significant in the anxiety and aggression subgroups (respectively:
p = 0.094, η2G = 0.019; p = 0.083, η
2
G = 0.036).
Concerning the no-signal RT, no significant effects of active
v. sham tDCS appeared either (Stimulation group main effect:
p = 0.338, η2G = 0.012; Stimulation group × Time interaction:
p = 0.309, η2G = 0.003), although participants did become faster
over sessions (main effect of Time: p < 0.001, η2G = 0.024). For fur-
ther details on the no-signal RT, see online Supplementary Fig. S2.
In an additional analysis, we explored if tDCS effects on
inhibitory control training would depend on baseline levels of
inhibitory control, which was assessed by the go/no-go task. To
that end, we regressed the total SSRT improvement from sessions
1 to 5 on the predictors pre-assessment Go/no-go scores (RT and
4 Fenne M. Smits et al.
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accuracy) and Stimulation group. Results showed no evidence for
a dependence of tDCS effects on baseline inhibitory control per-
formance (Stimulation group × Go/NoGo scores interaction effects:
p’s > 0.418). Analysis details can be found in the online
Supplementary materials.
Secondary outcomes of inhibitory control
Means and standard deviations per group are reported in Table 2,
together with the outcomes of the Stimulation group × Time inter-
action effects of interest.
Go/no-go task
Go/no-go data from 80 participants were available for analysis
(40 tDCS, 40 sham; missings due to insufficient (<100) completed
trials, n = 5; post-assessment unavailable or completed >1 week
after tDCS intervention, n = 11). TDCS did not influence response
speed or response inhibition accuracy: pre-to-post intervention
changes in RT or no-go accuracy were not significantly different
between active and sham tDCS groups (see Table 2). Response
speed did not significantly change over time or differ between
groups at all (main effect Time: p = 0.273, Stimulation group:
p = 0.374). For accuracy, a significant Go/no-go × Time interaction
Table 1. Demographical and clinical participant characteristics with mean and standard deviation values or count
Active tDCS
(n = 47) Sham (n = 49)
Gender Male: 41 48
Female: 6 1
Age (years)a 40.5 (10.6) 44.4 (9.4)
Education levelb Low: 4 1
Moderate: 30 30
High: 13 18
Military status Active-duty: 29 40
Post-active veteran: 18 9
Number of deployments 2.6 (2.6) 3.3 (2.0)
Years since last deployment (years) 12.9 (11.3) 12.8 (10.0)
Treatment type during tDCS interventionc EMDR: 8 8
CBT: 22 26
Other: 17 15
Use of psychoactive medicationd Yes: 18 15
No: 29 34
Childhood trauma (based on CTQ-SF cut-off scores for moderate




ADHD diagnosis Yes: 7 6
No: 40 43
Attentional impulsivity (BIS-11) 20.4 (3.5) 20.6 (3.5)
Motor impulsivity (BIS-11) 21.9 (3.6) 22.7 (3.4)
Non-planning impulsivity (BIS-11) 28.7 (4.4) 27.4 (4.7)
Diagnosise:
Impulsive aggression 23 22
Anxiety 16 24
PTSD 25 25
aAge was entered as a covariate in the statistical analyses. Excluding the Age covariate from the models did not significantly change the results.
bEducation level: low = high school education only, moderate = vocational degree, high = higher education degree.
cEMDR, eye movement desensitization and reprocessing therapy; CBT, cognitive behavioral therapy. Other treatments included: aggression regulation training, mindfulness-based therapy,
couples therapy, maintenance therapy by social workers, and pharmacological treatment.
dThe majority of psychoactive drugs used in our sample comprised selective serotonin or serotonin-norepinephrine reuptake inhibitors (SSRI’s and SNRI’s), benzodiazepines, atypical
antipsychotic drugs, norepinephrine-dopamine reuptake inhibitors (NDRI’s), and anticonvulsants. Analysis of the primary outcome measure (SST training scores) showed similar results
across medicated and unmedicated patients. Also, excluding Use of psychoactive medication ( yes/no) as a covariate from the models did not significantly change the results of any other
measure.
eWhile most participants fulfilled criteria for either PTSD or anxiety or impulsive aggression, some participants fulfilled criteria for multiple stress-related diagnoses: PTSD and anxiety (n = 10),
PTSD and impulsive aggression (n = 14), anxiety and impulsive aggression (n = 6), or all three diagnoses (n = 5).
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( p = 0.005; β = 0.41, std. error = 0.15) and a significant
Stimulation group × Time interaction appeared ( p = 0.008;
β = −0.17, std. error = 0.06). Bonferroni-corrected pairwise
t tests showed that go-trial accuracy increased from pre- to post-
assessment in both stimulation groups (go-trials – pre v. post:
p < 0.001). Such effects were not found for no-go accuracy (i.e.
response inhibition accuracy – pre v. post: p > 0.999). Moreover,
the stimulation groups differed in overall performance accuracy
at post-assessment, where the sham group made significantly
less errors than the active tDCS group (pre-assessment – active
tDCS v. sham: p = 0.898; post-assessment – active tDCS
v. sham: p = 0.011), suggesting a lack of improvement in overall
performance accuracy over time in the active tDCS group.
Again, no group differences were found specifically in no-go
accuracy (response inhibition). Furthermore, the face distractors
significantly impaired task performance: Distractor condition
showed a significant main effect on both RT and accuracy ( p’s
< 0.001). Follow-up t tests and χ2 tests showed that RTs were fas-
ter on trials with face distractors (distractor v. no-distractor: p <
0.001, neutral v. angry distractor: p = 0.690). This distractor-
induced RT acceleration also yielded a Stimulation group ×
Distractor condition interaction ( p = 0.047), showing it was
more pronounced in the active v. sham tDCS group ( p = 0.034).
Error rates increased from no-distractor- to neutral face
distractor- to angry face distractor-trials ( p’s < 0.045).
IAT
IAT data from 84 participants were available for analysis (43
tDCS, 41 sham; missings due to post-assessment unavailable or
completed >1 week after tDCS intervention, n = 12). Pre-to-post
intervention changes in the D600 IAT effect did not significantly
differ between the active tDCS and sham group (see Table 2). The
IAT effect significantly increased from pre- to post-assessment
( p = 0.042, η2G = 0.021), indicating a possible reduction in inhibi-
tory control over biases due to automatic associations. The Quad
model ‘overcoming bias’ parameter did not appear significantly
affected by Stimulation group, but the overall model fit was very
low suggesting the Quad model results were not reliable (model
fit for post-assessment IAT data – tDCS group: G2(6) = 11.33,
p = 0.079, AIC = 23.33; sham: group G2(6) = 13.00, p = 0.043,
AIC = 25.00). The full analysis is reported in the online
Supplementary materials.
Symptoms
The analysis of PTSD symptoms was only carried out within the
subgroup of PTSD patients, the analysis on anxiety symptoms
only within the subgroup of anxiety patients, and likewise for
the impulsive aggression patients. Data were available for analysis
per diagnosis subgroup as indicated in Table 2 (missings due to
unavailable post-assessment or completed >1 week after tDCS
intervention: PTSD: n = 5; anxiety: n = 2; aggression: n = 3).
Beside an overall significant reduction in symptom levels over
time (main effect of Time: p’s < 0.001, η2G’s > 0.008), the active
tDCS v. sham groups did not significantly differ in symptom
levels reductions, except for a slightly stronger reduction in
PCL-5 scores in the active tDCS v. sham group due to higher
baseline PTSD symptoms levels in the active tDCS group (see
Table 2 and Fig. 2). When the 3-months and 1-year follow-ups
were taken into account, these results did not substantively
change, see Table 2. PANAS Positive Affect and STAXI-2
Anger Expression and Control scales did not show significant
effects of tDCS v. sham (statistical results are reported in the
online Supplementary material).
Exploratory analyses on the relation between inhibitory
control and symptom severity
At baseline, higher symptom severity on all scales significantly
correlated with worse stop-signal task inhibitory control perform-
ance, see Table 3. Baseline no-go-accuracy significantly correlated
with PCL-5 and BDI-II scores. No other baseline inhibitory con-
trol measure correlated significantly with symptom levels.
Fig. 2. Mean SSRT (a) and mean item scores on symptom scales (b) ± S.D. per stimu-
lation group. N.S., non-significant. Please note that symptom scales were analyzed per
subgroup of patients with the corresponding diagnosis, and that drop-out at
follow-up reduced the sample sizes for FU-3m and FU-1yr assessments, see also
Table 2.
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Table 2. Statistical outcomes of non-trained inhibitory control and symptom measures
Go/no-go task – Go trial RT
(in ms)
Go/no-go task – total No-go










η2 G < .001
Group × Time ×
Distractor:
p = .310













0.67 ± .38 Group × Time:
p = .140
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η2 G < .001




































































1.42 ± .57 1.63 ± .60 1.75 ± .70 Group × Subscale × Time
Pre-Post:
p = .266
η2 G < .001








1.28 ± .59 1.49 ± .56 1.50 ± .72




1.29 ± .60 1.43 ± .56 1.58 ± .72




1.13 ± .57 1.37 ± .51 1.34 ± .68




1.57 ± .60 1.43 ± .56 1.77 ± .53




1.43 ± .62 1.35 ± .53 1.62 ± .51




1.34 ± .65 1.27 ± .39 1.48 ± .59




1.37 ± .66 1.28 ± .46 1.41 ± .68
FU3m = 3-months follow-up assessment. FU1yr = 1-year follow-up assessment.
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The overall improvement in SSRT or the achieved level of
SSRT on session 5 did not significantly predict symptom reduc-
tions (all p’s > 0.28, full statistical outcomes are reported in the
online Supplementary material). These results suggest no link
between short-term inhibitory control improvements and symp-
tom relief.
Discussion
Inhibitory control is thought to play a role in symptoms of PTSD,
anxiety, and impulsive aggression. Here, the effects of a
tDCS-combined inhibitory control training on pre–post measures
of inhibitory control and symptoms were for the first time inves-
tigated in a preregistered RCT with a large clinical sample of mili-
tary patients with these stress-related disorders. Contrary to
previous findings (Ditye et al., 2012), we failed to find an effect
of anodal tDCS over the right IFG v. sham on performance during
the stop-signal task inhibitory control training. No support was
found either for tDCS effects on post-intervention non-trained
inhibitory control nor on symptom levels of PTSD, anxiety, or
impulsive aggression. Hence, despite positive effects of tDCS
on inhibitory control in healthy individuals (Mayer et al.,
2020) and on symptoms of PTSD and anxiety in patients
(Ahmadizadeh, Rezaei, & Fitzgerald, 2019; van ’t Wout-Frank,
Shea, Larson, Greenberg, & Philip, 2019; Vicario, Salehinejad,
Felmingham, Martino, & Nitsche, 2019), we found no evidence
to support that right IFG tDCS combined with inhibitory control
training with our experimental set-up can effectively improve
inhibitory control or stress-related symptoms in these patients.
These results raise questions on why the tDCS effects on inhibi-
tory control did not replicate in our clinical sample, and, subse-
quently, what may be more effective ways to modulate clinically
relevant cognitive processes and stress-related symptoms with
non-invasive brain stimulation.
Effects of tDCS-combined training on inhibitory control
A substantial body of single-session tDCS research (Mayer et al.,
2020; Schroeder et al., 2020) and a multiple-session tDCS-training
intervention study (Ditye et al., 2012) in healthy participants
showed successful improvements in inhibitory control perform-
ance with tDCS settings not so different from ours (current inten-
sity: 1–1.5 mA; anode over the right IFG; cathode on left orbital
area or left cheek; duration: 10–30 min). Compared to the study
of Ditye and coworkers, we extended the training and stimulation
duration per session. Yet, the effects of tDCS were not replicated.
Perhaps by using a current density on the low end (0.036 mA/
cm2) of the range used for successful tDCS-enhanced stop-signal
task performance in other studies (0.028–0.125 mA/cm2) (Mayer
et al., 2020), the induced electrical field was too weak to modulate
right IFG activity to an extent that would produce measurable
behavioral changes [see, e.g. Li et al. (2019)]. On the other
hand, higher current densities do not necessarily follow a linear
increase of tDCS effectivity (Yavari et al., 2018).
Secondly, although we used a montage as applied by other
studies stimulating the IFG, there is uncertainty about the
anode placement relative to the IFG. Simulations of the electrical
field on one example brain showed a peak intensity located
slightly above the IFG (see online Supplementary Fig. S1).
Although inconclusive, the target region may have received sub-
optimal stimulation. To more effectively target inhibitory control,
the anode could be placed somewhat lower to better focus the
electrical field on the right IFG, e.g. on 10-20 system EEG positions
F8 or F10 (Coffman et al., 2012; Schroeder et al., 2020), or higher,
e.g. on position F4 to focus the field on the dorsolateral PFC
(Dousset et al., 2020; Salehinejad, Wischnewski, Nejati, Vicario, &
Nitsche, 2019). However, tDCS with the anode placed on the
F8-Cz Fz-T4 crossing, as in our study, has also shown successful
response inhibition enhancement (Mayer et al., 2020; Schroeder
et al., 2020). Technical tDCS parameter settings therefore do not
seem to fully explain our null results.
Alternatively, we possibly over-trained a relatively simple
inhibitory control task. As the primary physiological effects of
tDCS act upon ongoing neuronal and synaptic activity
(Kronberg, Bridi, Abel, Bikson, & Parra, 2017; Liebetanz, 2002;
Nitsche & Paulus, 2000), tDCS appears suitable to enhance pro-
cesses that depend on synaptic plasticity, like learning and mem-
ory processes. Correspondingly, in Ditye’s study (Ditye et al.,
2012), tDCS seemed to act as a necessary condition for an inhibi-
tory control learning effect to occur. However, our extended train-
ing sessions produced clear learning curves in both stimulation
groups, and we found no support for baseline inhibitory control
performance to predict tDCS effectivity. Together with indica-
tions that tDCS-enhancement can supersede after experience-
dependent learning [see, e.g. Fehring et al. (2019)], this suggests
that tDCS might have had little opportunity to further enhance
Table 3. Correlation matrix with baseline measures of symptom severity and inhibitory control.
1 2 3 4 5 6 7
1. PCL-5
2. PANAS negative affect 0.72**
3. STAXI-2 trait anger 0.31* 0.33*
4. BDI-II 0.74** 0.69** 0.22*
5. SSRT (reversed) −0.50** −0.33* −0.25* −0.36**
6. Go/no-go: RT −0.04 0.08 −0.04 −0.01 0.04
7. Go/no-go: no-go accuracy −0.27* −0.18 −0.01 −0.31* 0.43** 0.15
8. IAT effect (reversed) 0.15 0.16 0.01 0.20 −0.01 0.16 0.06
Higher symptom scores reflect higher symptom severity, lower (reversed) inhibitory control scores reflect worse inhibitory control performance. Note that the SSRT used for the baseline
correlations was measured during the first tDCS session.
* p < 0.05, **p < 0.001.
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training processes in our study. Moreover, patients with stress-
related disorders may specifically show impulsivity in the emo-
tional domain (Johnson, Carver, & Joormann, 2013), and tDCS
effects on cognitive and emotional outcomes seem to depend
on active emotion regulation, cognitive effort and neural activity
in the targeted area (Gill, Shah-basak, & Hamilton, 2015; Nord
et al., 2019; Smits et al., 2020). Our response inhibition training
may have failed to adequately incorporate these factors due to
its non-emotional nature and low cognitive load. Also, non-
trained inhibitory control tasks (go/no-go task and IAT) showed
no evidence for tDCS effects, in line with expectations that effects
do not transfer in the absence of tDCS effects on trained tasks
(Berryhill & Martin, 2018). Altogether, conditions for tDCS effi-
cacy in these patients may crucially include emotionally challen-
ging tasks during stimulation.
Effects of tDCS-combined training on symptoms
In light of the null-effects on inhibitory control, the tDCS inter-
vention would not affect symptom levels of PTSD, anxiety, and
aggression via such mediating cognitive processes. On the other
hand, tDCS effects on symptoms without concurrent cognitive
improvement have previously been shown in depression
(Martin et al., 2018) and PTSD patients (Ahmadizadeh et al.,
2019), suggesting that prefrontal tDCS may also affect symptoms
via other mechanisms. However, on stress-related as well as mood
symptoms and general mental well-being, no evidence for tDCS
effects was found. Possibly, such non-specific tDCS effects require
more sessions and a shorter between-session-interval (max. 1 day)
(Alonzo, Brassil, Taylor, Martin, & Loo, 2012). Patients in both
stimulation groups did show significant symptom reduction
over the course of the intervention, presumably as a result primar-
ily of ongoing therapeutic processes of regular treatment.
Future directions
To find more effective ways to target stress-related symptoms with
tDCS, the next steps should be to identify what are the relevant
brain processes that facilitate recovery, and to determine under
what conditions tDCS effectively modulates those brain processes.
Brain state may constitute one of the most important but also
unresolved factors of influence on tDCS effectivity. Whereas we
intended to attune brain states during the intervention across par-
ticipants by applying a concurrent cognitive task, the combination
with neuroimaging methods can help to better study brain state in
parallel to the behavioral and clinical effects of tDCS [see, e.g.
Nord et al. (2019)]. Regarding inhibitory control as a cognitive
target, exploratory analyses confirmed the association with stress-
related symptoms, but not with symptom relief. An alternative
target may be tDCS over the dorsolateral PFC (Brunoni &
Vanderhasselt, 2014) to modulate working memory deficits in
stress-related disorders [see e.g. Scott et al. (2015)] which can con-
tribute to symptom relief (Schweizer et al., 2017). Successful
attempts to enhance effects of cognitive behavioral or exposure
psychotherapy with prefrontal stimulation (Herrmann et al.,
2017; Nord et al., 2019; van ’t Wout-Frank et al., 2019) also sug-
gest that tDCS interventions might be further developed in exist-
ing clinical applications. More placebo-controlled clinical trials
are encouraged to examine whether this is a viable option.
Limitations
Limitations in our study may restrict the generalization of our
results. First, pre- and post-intervention measures were assessed
online. As a trade-off for a lower travel burden for patients
(Smits, de Kort, & Geuze, 2021), this could have reduced the
measurement sensitivity to detect (possibly weak) tDCS effects.
On the other hand, cognitive assessment through online experi-
ments appear reliable (Gladwin & Vink, 2020). Also, we carried
out this study in an (ex-)military, predominantly male sample.
Excluding data from female participants did not essentially
change the results, and our sample represented a broad and het-
erogeneous group, but military personnel in general may
represent a relatively homogenous population due to rigid selec-
tion and training procedures. Our outcomes may therefore not
directly translate to other populations.
Conclusion
The current RCT in military patients with stress-related symp-
toms provides no evidence for short-term or long-term benefits
of 5 sessions of 20-min tDCS targeting the right IFG at an inten-
sity of 1.25 mA combined with response inhibition training, on
inhibitory control or PTSD, anxiety, and impulsive aggression
symptoms. For these patients, tDCS may be more effective in
higher doses (e.g. higher current density, more sessions) or
when combined with emotionally challenging tasks or psycho-
therapy. Gaining insight in determinants of tDCS efficacy and
convenient brain targets for neuromodulation in stress-related
disorders will allow the tailoring of future tDCS interventions.
Supplementary material. The supplementary material for this article can
be found at https://doi.org/10.1017/S0033291721000817
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